Skip to main content
Veterinary Medicines

Panacur PetPaste 187.5 mg/g oral paste for dogs and cats

Authorised
  • Fenbendazole

Product identification

Medicine name:
Panacur PetPaste 187.5 mg/g oral paste for dogs and cats
Panacur PetPaste 187.5 mg/g oral paste for dogs and cats
Active substance:
  • Fenbendazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    187.50
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral paste
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • (ID2) 48 gram(s): unspecified outer container with 10 Applicator each with 4.8 gram(s)
  • (ID1) 4.8 gram(s): unspecified outer container with 1 Applicator with 4.8 gram(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/188/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0109/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Greece
  • Hungary
  • Ireland
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download

Combined File of all Documents

English (PDF)
Published on: 14/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."